Skip to content

To study that whether giving oral contraceptives regularly to sheehans patients increases their bone strength

To study the effect of sex steroid replacement on BMD in follow up patients of Sheehans syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/04/006786
Enrollment
30
Registered
2016-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient had multiple hormone deficiencies, developed after post partum period due to pituitary necrosis

Interventions

Intervention1: Oral contraceptive pills contains estrogen and progesterone: patients were given OCPs for 21 days in a month for 1 year then BMD was compared before and after giving drug Intervention2:

Sponsors

SGPGIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Absent lactation and/or PPH (postpartum hemorrage)and Menstrual disturbances after last delivery 2. Clinical evidence of deficiency of one or more pituitary hormones 3. Documentation of deficiency of at least one pituitary hormone 4. Absence of clinical or radiological feature of pituitary mass lesion

Exclusion criteria

Exclusion criteria: 1. Other etiologies of hypopituitarism 2. Age > 42 years 3. Patients with chronic diseases like uncontrolled diabetes, CAD, CKD, Liver disease and chronic inflammatory disorders 4. Patient with history of thromboembolic disorders 5. Patients with suspected breast, endometrial or cervical cancer 6. Patients on supra-physiological doses of steroids, anti-epileptic drugs and bisphosphonates

Design outcomes

Primary

MeasureTime frame
To study the effect on BMD after sex steroid replacement in the follow up patients of Sheehans syndrome Timepoint: 1 year follow up

Secondary

MeasureTime frame
morbidity fracture incidenceTimepoint: 1 year follow up

Countries

India

Contacts

Public ContactDr Purnima Agarwal

Sanjay Gandhi Postgraduate Institute of Medical Sciences

subhash70@gmail.com8004904670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026